Could be but more likely there will be multiple "winners". Not sure that the lipid component will be major factor for many but it could be for those who are averse to stains/have Hypertriglyceridemia in addition to being obese. Reducing liver fat will be another category some will look at. Both injectables and orals will be employed.
Again- in the end, I believe the most successful drugs will have the tolerability/safety as their most important characteristic.
Market Data 
Markets 
AI
